# Deciphering the Molecular Traits of Non-canonical Responders to Advance Personalized Therapy in Gastric Cancer

> **NCT06877910** · — · ACTIVE_NOT_RECRUITING · sponsor: **Regina Elena Cancer Institute** · enrollment: 220 (estimated)

## Conditions studied

- Metastatic Gastric Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06877910
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-01-10
- **Primary completion:** 2023-06-20
- **Final completion:** 2026-01-10
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2025-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06877910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06877910, "Deciphering the Molecular Traits of Non-canonical Responders to Advance Personalized Therapy in Gastric Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06877910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*